-
UPDATE: Benchmark Company Downgrades ARM Holdings plc on Less Favorable View of Chip Sector
Monday, October 28, 2013 - 11:11am | 169In a report published Monday, Benchmark Company analyst Gary Mobley downgraded the rating on ARM Holdings plc (NASDAQ: ARMH) from Buy to Hold, and lowered the price target from $54.00 to $50.00. In the report, Benchmark Company noted, “Due primarily to our less favorable opinion of the chip group...
-
UPDATE: Benchmark Company Reiterates on Amazon.com Following Surprise 3Q Revenue Beat
Friday, October 25, 2013 - 9:05am | 211In a report published Friday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating on Amazon.com (NASDAQ: AMZN), and raised the price target from $350.00 to $400.00. In the report, Benchmark Company noted, “Amazon (AMZN-Buy, PT from $350 to $400) reported a surprise 3Q revenue beat,...
-
UPDATE: Benchmark Company Initiates Coverage on LeMaitre Vascular on Multiple Positive Factors
Thursday, October 24, 2013 - 10:35am | 170In a report published Thursday, Benchmark Company analyst Jan Wald initiated coverage on LeMaitre Vascular (NASDAQ: LMAT) with a Buy rating and $9.00 price target. In the report, Benchmark Company noted, “We are initiating coverage on LeMaitre Vascular with a Buy rating and a $9 price target. We...
-
Benchmark Reiterates Buy on eBay as Weak Holiday Outlook Clouds Consistent Fundamental Improvement
Thursday, October 17, 2013 - 9:22am | 139In a report published Thursday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating and $63.00 price target on eBay (NASDAQ: EBAY). In the report, Benchmark Company noted, “eBay (EBAY-Buy, PT $63) reported in-line 3Q results, with outperformance in Marketplaces revenue and...
-
UPDATE: Benchmark Initiates Coverage on Insulet Corporation Following Strong Response to New OmniPod
Tuesday, October 15, 2013 - 11:30am | 145In a report published Tuesday, Benchmark Company analyst Jan Wald initiated coverage on Insulet Corporation (NASDAQ: PODD) with a Buy rating and $44.00 price target. In the report, Benchmark Company noted, “We are initiating coverage of Insulet with a Buy rating and $44 price target. Our view is...
-
UPDATE: Benchmark Initiates Coverage on DexCom on Upside From New G4 Platinum Sensor
Tuesday, October 15, 2013 - 11:30am | 148In a report published Tuesday, Benchmark Company analyst Jan Wald initiated coverage on DexCom (NASDAQ: DXCM) with a Buy rating and $37.00 price target. In the report, Benchmark Company noted, “We are initiating coverage of Dexcom with a Buy rating and a $37 price target, supported by the upside...
-
Benchmark Reiterates Buy on eBay Ahead of 3Q13 Results Report
Tuesday, October 15, 2013 - 9:32am | 198In a report published Tuesday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating and $63.00 price target on eBay (NASDAQ: EBAY). In the report, Benchmark Company noted, “eBay (EBAY-Buy, PT $63) is set to report 3Q13 results on Wednesday after the close. Until the recent...
-
UPDATE: Benchmark Initiates Coverage on IMAX on Near-Term Optimism, Ongoing Performance Risk
Wednesday, October 2, 2013 - 9:09am | 127In a report published Wednesday, Benchmark Company analyst Mike Hickey initiated coverage on IMAX Corporation (NYSE: IMAX) with a Hold rating and $29.42 price target. In the report, Benchmark Company noted, “We remain optimistic near term over the IMAX brand and premium ticket experience they...
-
UPDATE: Benchmark Initiates Coverage on Abiomed on Potential of Impella Device
Tuesday, October 1, 2013 - 8:57am | 188In a report published Tuesday, Benchmark Company analyst Jan Wald initiated coverage on Abiomed (NASDAQ: ABMD) with a Speculative Buy rating and $25.00 price target. In the report, Benchmark Company noted, “We are initiating coverage of Abiomed with a Speculative Buy rating and Price Target of $25...
-
UPDATE: Benchmark Initiates Coverage on Sunshine Heart on Potential of C-Pulse Heart Assist System
Tuesday, October 1, 2013 - 8:57am | 202In a report published Tuesday, Benchmark Company analyst Jan Wald initiated coverage on Sunshine Heart (NASDAQ: SSH) with a Speculative Buy rating and $16.00 price target. In the report, Benchmark Company noted, “We are initiating coverage of Sunshine Heart with a Speculative Buy rating and Price...
-
UPDATE: Benchmark Raises PT on Move on Positive Outlook
Monday, September 30, 2013 - 8:55am | 183In a report published Monday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating on Move (NASDAQ: MOVE), and raised the price target from $17.00 to $23.00. In the report, Benchmark Company noted, “We believe Move (MOVE-Buy) continues to gain traction across its entire product suite...
-
Benchmark Reiterates Buy on InterNAP Network Services Following Philadelphia Meetings
Monday, September 23, 2013 - 11:01am | 135In a report published Monday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating and $12.00 price target on InterNAP Network Services (NASDAQ: INAP). In the report, Benchmark Company noted, “We recently hosted Internap (INAP-Buy, PT $12) in Philadelphia. Our meetings reinforced our...
-
UPDATE: Benchmark Lowers PT on R.R. Donnelley Following Recent Investor Conference
Tuesday, September 17, 2013 - 12:12pm | 156In a report published Tuesday, Benchmark Company analyst Edward J. Atorino reiterated a Hold rating on R.R. Donnelley & Sons Co. (NASDAQ: RRD), but lowered the price target from $20.00 to $19.00. In the report, Benchmark Company noted, “At a recent investor conference, RRD (RRD-Hold, PT from $...
-
UPDATE: Benchmark Company Upgrades Guidance Software on More Balanced Risk/Reward Profile
Tuesday, September 17, 2013 - 11:01am | 166In a report published Tuesday, Benchmark Company analyst Mark W. Schappel upgraded the rating on Guidance Software (NASDAQ: GUID) from Sell to Hold, and reiterated the $9.00 price target. In the report, Benchmark Company noted, “Though we are concerned with a number of issues currently facing the...
-
UPDATE: Benchmark Company Reiterates on Perion Network Ltd. Following Announcement of Conduit Merger
Tuesday, September 17, 2013 - 9:41am | 182In a report published Tuesday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating on Perion Network Ltd. (NASDAQ: PERI), and raised the price target from $16.00 to $19.00. In the report, Benchmark Company noted, “Yesterday, Perion (PERI-Buy, PT from $16 to $19) announced it had...